Header Logo

Connection

Danny Dhanasekaran to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Danny Dhanasekaran has written about Drug Resistance, Neoplasm.
Danny Dhanasekaran
Connection Strength
1.564
Drug Resistance, Neoplasm
  1. Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer. Cancer Lett. 2024 Jun 01; 591:216891.
    View in: PubMed
    Score: 0.830
  2. Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy. Cells. 2021 11 17; 10(11).
    View in: PubMed
    Score: 0.175
  3. Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells. Oncogene. 2019 11; 38(45):7089-7105.
    View in: PubMed
    Score: 0.150
  4. Activation of LXR?/? by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer. BMC Cancer. 2018 Dec 10; 18(1):1232.
    View in: PubMed
    Score: 0.143
  5. Tumour microenvironment on mitochondrial dynamics and chemoresistance in cancer. Free Radic Res. 2018 Dec; 52(11-12):1271-1287.
    View in: PubMed
    Score: 0.137
  6. MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017 05 22; 8:14634.
    View in: PubMed
    Score: 0.129
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.